Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Basic tumor immunology

Original research

Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression

Online download statistics by month:

Online download statistics by month: June 2022 to March 2024

	Abstract	Full	Pdf
Jun 2022	684	708	372
Jul 2022	441	447	200
Aug 2022	290	290	74
Sep 2022	251	260	94
Oct 2022	297	301	98
Nov 2022	176	176	72
Dec 2022	169	169	72
Jan 2023	136	136	63
Feb 2023	171	177	114
Mar 2023	139	139	86
Apr 2023	122	122	62
May 2023	105	108	59
Jun 2023	120	120	59
Jul 2023	118	118	72
Aug 2023	383	383	61
Sep 2023	100	100	53
Oct 2023	114	114	78
Nov 2023	147	147	85
Dec 2023	158	158	114
Jan 2024	141	142	116
Feb 2024	105	106	82
Mar 2024	189	190	193
Total	4556	4611	2279